The Benefits Of Aspirin For Covid
Remember I included Aspirin in the Covid treatment protocol?
A new study finds that simple, over-the-counter aspirin may be able to protect COVID-19 patients from extreme risk, including the need for mechanical ventilation, the Jerusalem Post reported.
New research from George Washington University has determined that treating COVID patients with aspirin reduced the risk of severe illness by nearly half.
The report noted that an aspirin regimen in more than 400 COVID-19 patients in hospitals across the United States cut the need for ventilation by 44%, slashed ICU admission by 43%, and reduced overall in-hospital mortality rates by 47%.
Dr. Jonathan Chow, one of the study’s researchers, said, “As we learned about the connection between blood clots and COVID-19, we knew that aspirin — used to prevent stroke and heart attack — could be important for COVID-19 patients. Our research found an association between low-dose aspirin and decreased severity of COVID-19 and death.”
A low-dose aspirin regimen has long been touted as potentially lifesaving for people at risk of heart attack or stroke or who are afflicted by blood clotting issues.
This isn’t the only study professing the possible benefits of aspirin in COVID patients. Earlier in October, Medical Express reported that researchers from the University of Minnesota and Basel University in Switzerland came to the same conclusion.
The researchers’ findings were published in Lancet’s Open Access eClinical Medicine and revealed that patients on blood thinners before getting COVID were admitted less often to the hospital despite being older and having more chronic medical conditions than their peers. The findings also revealed that blood thinners — whether started before or after COVID-19 infection — reduced death by nearly half.
Such a simple, simple thing as aspirin. My pediatrician was prescribing baby aspirin to me when I was an infant.
But there isn’t any money in it for big pharma if we just kill Covid with aspirin, is there?

